# Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

> **NCT06896981** · PHASE2,PHASE3 · RECRUITING · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 30 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome (PCOS) Women
- Obesity

## Interventions

- **DRUG:** Metformin with Semaglutide

## Key facts

- **NCT ID:** NCT06896981
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06896981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06896981, "Semaglutide in Women With Polycystic Ovary Syndrome and Obesity". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06896981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*